# Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia

> **NCT00999505** · PHASE3 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 40 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Amantadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00999505
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00999505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00999505, "Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT00999505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*